Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Australian Stock Exchange  >  Fisher & Paykel Healthcare Corporation Limited    FPH   NZFAPE0001S2

FISHER & PAYKEL HEALTHCARE CORPORATION LIMITED

(FPH)
  Report
 SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Australian Stock Exchange
01/19/2021 01/20/2021 01/21/2021 01/22/2021 01/25/2021 Date
29.77 30.8 30.7 32.5 32.91 Last
981027 611136 426683 772096 649129 Volume
+1.85% +3.46% -0.32% +5.86% +1.26% Change
Financials
Sales 2021 1 956 M 1 408 M 1 408 M
Net income 2021 507 M 365 M 365 M
Net cash position 2021 113 M 81,6 M 81,6 M
P/E ratio 2021 38,8x
Yield 2021 1,21%
Sales 2022 1 715 M 1 234 M 1 234 M
Net income 2022 411 M 296 M 296 M
Net cash position 2022 245 M 176 M 176 M
P/E ratio 2022 48,0x
Yield 2022 1,40%
Capitalization 20 374 M 14 636 M 14 664 M
EV / Sales 2021 10,4x
EV / Sales 2022 11,7x
Nbr of Employees 4 731
Free-Float 99,6%
More Financials
Company
Fisher & Paykel Healthcare Corporation Limited designs, manufactures and markets medical device products and systems for use in respiratory care, acute care, surgery and the treatment of obstructive sleep apnea. The Company’s segment includes North America, which includes all activities controlled by entities or employees based in the United States and Canada; Europe, which includes all activities controlled by... 
More about the company
Notations Surperformance© of Fisher & Paykel Healthcare Corporation Limited
Trading Rating : Investor Rating :
More Ratings
All news about FISHER & PAYKEL HEALTHCARE CORPORATION LIMITED
01/21FISHER & PAYKEL HEALTHCARE : Rises 5% on Higher Revenue, Profit Expectations in ..
MT
01/21FISHER & PAYKEL HEALTHCARE : & Paykel's 9-Month Revenue Surged 73% on Coronaviru..
DJ
01/21FISHER & PAYKEL HEALTHCARE : provides FY21 trading update
PU
2020Australia shares fall as new virus strain clouds recovery hopes
RE
2020FISHER & PAYKEL HEALTHCARE : wins Zenith Award from the American Association for..
PU
2020Australia shares fall on COVID-19 vaccine production halt, post sixth weekly ..
RE
2020FISHER & PAYKEL HEALTHCARE : named Company of the Year and Lewis Gradon Chief Ex..
PU
2020FISHER & PAYKEL HEALTHCARE CORPORATI : Bonus dividend due to over-provision of t..
FA
2020FISHER & PAYKEL HEALTHCARE CORPORATI : Ex-dividend day for interim dividend
FA
2020FISHER & PAYKEL HEALTHCARE : F&P Healthcare Raises Guidance as Pandemic Boosts S..
DJ
2020FISHER & PAYKEL HEALTHCARE : F&P Healthcare Raises Guidance as Pandemic Boosts S..
DJ
2020RECORD HALF YEAR RESULT FOR FISHER & : net profit up 86%
PU
2020Australia shares at near 9-month high as biggest states reopen borders
RE
2020FISHER & PAYKEL HEALTHCARE CORPORATI : half-yearly earnings release
2020Australia shares end lower as traders shun risk on virus surge
RE
More news
News in other languages on FISHER & PAYKEL HEALTHCARE CORPORATION LIMITED
2020MÄRKTE ASIEN/Börsen durch die Bank im Minus
2020MÄRKTE ASIEN/Börsen drehen nach unten ab
2020FISHER & PAYKEL HEALTHCARE CORPORATI : publication des résultats semestriels
2020FISHER & PAYKEL HEALTHCARE CORPORATI : Veröffentlichung des Halbjahresergebnisse..
More news
Analyst Recommendations on FISHER & PAYKEL HEALTHCARE CORPORATION LIMITED
More recommendations
Chart FISHER & PAYKEL HEALTHCARE CORPORATION LIMITED
Duration : Period :
Fisher & Paykel Healthcare Corporation Limited Technical Analysis Chart | FPH | NZFAPE0001S2 | MarketScreener
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus UNDERPERFORM
Number of Analysts 9
Average target price 31,60 NZD
Last Close Price 34,75 NZD
Spread / Highest target 9,87%
Spread / Average Target -9,07%
Spread / Lowest Target -36,7%
EPS Revisions
Managers and Directors
NameTitle
Lewis George Gradon Chief Executive Officer, Director & MD
Scott Andrew St. John Chairman
Lyndal York Chief Financial Officer
Andrew Robert Donald Somervell Vice President-Products & Technology
Nicholas Fourie VP-Information & Communication Technology
Sector and Competitors
1st jan.Capitalization (M$)
FISHER & PAYKEL HEALTHCARE CORPORATION LIMITED6.33%14 636
ABBOTT LABORATORIES4.78%196 561
MEDTRONIC PLC-0.20%157 350
BECTON, DICKINSON AND COMPANY4.00%75 691
HOYA CORPORATION-3.92%49 122
ALIGN TECHNOLOGY, INC.0.95%42 537